ES2179909T3 - Cebadores de oligonucleotidos para la amplificacion del acido nucleico del vhc. - Google Patents

Cebadores de oligonucleotidos para la amplificacion del acido nucleico del vhc.

Info

Publication number
ES2179909T3
ES2179909T3 ES96118704T ES96118704T ES2179909T3 ES 2179909 T3 ES2179909 T3 ES 2179909T3 ES 96118704 T ES96118704 T ES 96118704T ES 96118704 T ES96118704 T ES 96118704T ES 2179909 T3 ES2179909 T3 ES 2179909T3
Authority
ES
Spain
Prior art keywords
nucleic acid
primers
amplification
hcv
oligonucleotide primers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96118704T
Other languages
English (en)
Inventor
Sue Yen Tsang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2179909T3 publication Critical patent/ES2179909T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • C12Q1/707Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA CEBADORES MEJORADOS PARA LA AMPLIFICACION DE UNA SECUENCIA DE ACIDO NUCLEICO DEL VIRUS DE LA HEPATITIS C (HCV), MEDIANTE REACCION EN CADENA DE LA POLIMERASA (PCR). LOS CEBADORES Y LOS METODOS DE AMPLIFICACION DE LA INVENCION, PERMITEN LA DETECCION DE HCV, CON UNA SENSIBILIDAD CONSIDERABLEMENTE MAYOR. LA INVENCION PROPORCIONA ASIMISMO EQUIPAMIENTOS QUE COMPRENDEN DICHOS CEBADORES, Y METODOS DE AMPLIFICACION DE UN ACIDO NUCLEICO DEL VIRUS DE LA HEPATITIS C (HCV) EN UNA MUESTRA, UTILIZANDO DICHOS CEBADORES. SE PROPORCIONAN TAMBIEN METODOS PARA DETECTAR ACIDO NUCLEICO DE HCV EN UNA MUESTRA, EN LA QUE DICHO ACIDO NUCLEICO HA SIDO AMPLIFICADO UTILIZANDO LOS CEBADORES MENCIONADOS ANTERIORMENTE.
ES96118704T 1995-11-29 1996-11-21 Cebadores de oligonucleotidos para la amplificacion del acido nucleico del vhc. Expired - Lifetime ES2179909T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US773995P 1995-11-29 1995-11-29

Publications (1)

Publication Number Publication Date
ES2179909T3 true ES2179909T3 (es) 2003-02-01

Family

ID=21727873

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96118704T Expired - Lifetime ES2179909T3 (es) 1995-11-29 1996-11-21 Cebadores de oligonucleotidos para la amplificacion del acido nucleico del vhc.

Country Status (8)

Country Link
US (1) US5837442A (es)
EP (1) EP0776981B1 (es)
JP (2) JP3814352B2 (es)
AT (1) ATE220726T1 (es)
CA (1) CA2191182C (es)
DE (1) DE69622347T2 (es)
DK (1) DK0776981T3 (es)
ES (1) ES2179909T3 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7070925B1 (en) 1996-07-16 2006-07-04 Gen-Probe Incorporated Method for determining the presence of an RNA analyte in a sample using a modified oligonucleotide probe
DE69827060T2 (de) * 1997-03-20 2005-03-24 F. Hoffmann-La Roche Ag Modifizierte Primer
ATE280839T1 (de) * 1999-02-03 2004-11-15 Ortho Clinical Diagnostics Inc Oligonukleotid primer zur effizienten reversen transkription von hepatitis c virus (hcv) rns und verfahren zu deren verwendung
US6638714B1 (en) * 1999-02-03 2003-10-28 Ortho-Clinical Diagnostics, Inc. Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
CA2644688C (en) * 1999-04-20 2012-11-13 Kankyo Engineering Co., Ltd. Method for determining a concentration of target nucleic acid molecules, nucleic acid probes for the method, and method for analysing data obtained by the method
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
CA2439402A1 (en) * 2001-03-02 2002-09-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pcr method
US20060068433A1 (en) * 2004-09-20 2006-03-30 Godfrey Tony E Multiple mode multiplex reaction quenching method
EP1236804A1 (en) * 2001-03-02 2002-09-04 Boehringer Mannheim Gmbh A method for determination of a nucleic acid using a control
US20030152942A1 (en) * 2001-05-09 2003-08-14 Lance Fors Nucleic acid detection in pooled samples
KR100440852B1 (ko) * 2001-05-10 2004-07-19 주식회사 바이로메드 레트로바이러스에 특이적인 올리고뉴클레오티드 프라이머및 이를 이용한 레트로바이러스 농도 측정방법
US6946245B2 (en) 2001-12-04 2005-09-20 Quest Diagnostics Investments Incorporated Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
ATE454470T1 (de) * 2002-07-26 2010-01-15 Abbott Lab Verfahren zum nachweis und zur quantifizierung von hepatitis-c-virus
US7820030B2 (en) 2003-04-16 2010-10-26 Handylab, Inc. System and method for electrochemical detection of biological compounds
US7824857B2 (en) * 2003-12-02 2010-11-02 Musc Foundation For Research Development Methods and compositions for diagnosing epithelial cell cancer
US7981616B2 (en) * 2004-02-27 2011-07-19 Musc Foundation For Research Development Enhanced detection of RNA using a panel of truncated gene-specific primers for reverse transcription
WO2006017150A2 (en) * 2004-07-09 2006-02-16 University Of Pittsburgh - Of The Commonwealth System Of Higher Educatiion Identification of markers in lung and breast cancer
WO2006085328A2 (en) * 2005-02-14 2006-08-17 Mor Research Applications Ltd. Method and kit for diagnosing and predicting hepatitis c virus-related neoplastic transformation
US8067208B2 (en) * 2005-06-30 2011-11-29 Roche Molecular Systems, Inc. Probes and methods for hepatitis C virus typing using multidimensional probe analysis
EP1910397A4 (en) 2005-07-15 2009-07-01 Applera Corp DESIGNED A HOT START TRANSFER THROUGH PRIMER
CA2571904A1 (en) * 2006-02-15 2007-08-15 Fio Corporation System and method of detecting pathogens
US8119352B2 (en) * 2006-06-20 2012-02-21 Cepheld Multi-stage amplification reactions by control of sequence replication times
CA2580589C (en) 2006-12-19 2016-08-09 Fio Corporation Microfluidic detection system
CA2682826C (en) 2007-04-02 2013-08-13 Fio Corporation System and method of deconvolving multiplexed fluorescence spectral signals generated by quantum dot optical coding technology
EP2162486A4 (en) 2007-06-22 2014-03-12 Fio Corp SYSTEM AND METHOD FOR PRODUCING QUANTUM POINT-DOTTED POLYMERMIC BEADS
JP5507454B2 (ja) 2007-07-09 2014-05-28 フィオ コーポレイション 試験サンプル中の標的分子の蛍光検出の向上のためのシステムおよび方法
WO2009028654A1 (ja) * 2007-08-31 2009-03-05 National University Corporation Tottori University TERT遺伝子のcDNAの製造、それを用いた核酸増幅法、検出方法、それらに用いるプライマー、及び、それらを用いた腫瘍の診断キット
EP2209549A4 (en) 2007-10-12 2014-03-05 Fio Corp FLOW FOCUSING SYSTEM AND SYSTEM FOR FORMING CONCENTRATED VOLUMES OF MICRO BEADS AND FURTHER MICRO BEADS
CA2729023C (en) 2008-06-25 2013-02-26 Fio Corporation Bio-threat alert system
MX2011002235A (es) 2008-08-29 2011-04-05 Fio Corp Dispositivo de prueba de diagnostico portatil de un solo uso, y un sistema y metodo asociado para probar muestras de prueba biologicas y ambientales.
CN104374932A (zh) 2009-01-13 2015-02-25 Fio公司 与电子设备和快速诊断测试中的测试盒结合使用的手持诊断测试设备

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5310652A (en) 1986-08-22 1994-05-10 Hoffman-La Roche Inc. Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription
US5322770A (en) 1989-12-22 1994-06-21 Hoffman-Laroche Inc. Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription
EP0318216B2 (en) 1987-11-18 2001-08-29 Chiron Corporation NANBV diagnostics
KR0185373B1 (ko) 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
CA2017157C (en) 1989-05-18 2003-07-29 Michael Houghton Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
US5035996A (en) 1989-06-01 1991-07-30 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
DE69131891T2 (de) 1990-02-16 2000-06-15 F. Hoffmann-La Roche Ag, Basel Verbesserungen in der spezifität und zweckmässigkeit der polymerase-kettenreaktion
DK0540693T3 (da) 1990-07-24 1999-09-13 Hoffmann La Roche Reduktion af ikke-specifik amplifikation under in vitro-nukleinsyreamplifikation under anvendelse af modificerede nukleinsy
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
EP0487218B1 (en) 1990-10-31 1997-12-29 Tosoh Corporation Method for detecting or quantifying target nucleic acid
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
PT787807E (pt) 1991-08-27 2003-08-29 Hoffmann La Roche Iniciadores e sondas para a deteccao da hepatite c
AU4387193A (en) * 1992-05-29 1993-12-30 Abbott Laboratories Ligase chain reaction starting with rna sequences
ATE205259T1 (de) * 1993-07-01 2001-09-15 Hoffmann La Roche Reagenz und verfahren für reverse transkription bei hoher temperatur, verbunden mit einer polymerase-kettenreaktion
WO1995006753A1 (en) * 1993-09-03 1995-03-09 The United States of America, represented by The Secretary, Department of Health & Human Services Method and compositions for primer specific solid-phase detection of pcr products
US5491063A (en) 1994-09-01 1996-02-13 Hoffmann-La Roche Inc. Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
US5571673A (en) 1994-11-23 1996-11-05 Hoffmann-La Roche Inc. Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
US9105210B2 (en) 2012-06-29 2015-08-11 Microsoft Technology Licensing, Llc Multi-node poster location

Also Published As

Publication number Publication date
EP0776981A2 (en) 1997-06-04
EP0776981B1 (en) 2002-07-17
JPH09163991A (ja) 1997-06-24
ATE220726T1 (de) 2002-08-15
JP3903059B2 (ja) 2007-04-11
DE69622347D1 (de) 2002-08-22
US5837442A (en) 1998-11-17
DE69622347T2 (de) 2003-02-13
JP3814352B2 (ja) 2006-08-30
JP2006020642A (ja) 2006-01-26
CA2191182A1 (en) 1997-05-30
CA2191182C (en) 2004-09-21
DK0776981T3 (da) 2002-11-11
EP0776981A3 (en) 1998-08-19

Similar Documents

Publication Publication Date Title
ES2179909T3 (es) Cebadores de oligonucleotidos para la amplificacion del acido nucleico del vhc.
AU665952B2 (en) Methods and reagents for hepatitis C detection
NO20000536D0 (no) Oligonukleotidprimere for effektiv deteksjon av Hepatitis C- virus (HCV) og metoder for anvendelse derav
DE69627408D1 (de) Primers und Sonden zum Nachweis von HIV
AU650055B2 (en) Nucleotide sequences useful as type-specific probes, PCR primers and LCR probes for the amplification and detection of human papilloma virus, and related kits and methods
DE69610933D1 (de) Verfahren und reagenzien zur typisierung von hla-genen der klasse i
DE60015210D1 (de) Oligonukleotid Primer zur effizienten reversen Transkription von Hepatitis C Virus (HCV) RNS und Verfahren zu deren Verwendung
RU93013954A (ru) Способ обнаружения вируса иммунодефицита